VITRO DIAGNOSTICS INC | 2013 | FY | 3


           

 

October 31,

2013

 

October 31,

 2012

Tax credits for net operating loss carry forwards

$

   1,623,138 

 

$

    1,578,251 

Accrued officer salaries

 

      445,761 

 

 

        441,091 

Deferred tax asset (before valuation allowance)

 $

    2,068,899

 

     2,019,342 


us-gaap:SummaryOfDeferredTaxLiabilityNotRecognizedTextBlock